Enhanced CCR2 expression by ACKR2-deficient NK cells increases tumoricidal cell therapy efficacy.Published in:Journal of Leukocyte Biology, 2024, v. 116, n. 6, p. 1544, doi. 10.1093/jleuko/qiae162By:Hayes, Alan J;Pingen, Marieke;Wilson, Gillian;Hansell, Chris;Love, Samantha;Burgoyne, Paul;McElroy, Daniel;Bartolini, Robin;Vidler, Francesca;Schuette, Fabian;Gamble, Alistair;Campbell, Jordan;Galatis, Dimitrios;Campbell, John D M;Graham, Gerard JPublication type:Article